Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms

SIMPLE SUMMARY: The introduction of JAK inhibitors has provided objective benefits to many patients with myeloproliferative neoplasms. However, the overall efficacy of these drugs is limited and improved therapeutic options are required. Epigenetic dysregulation is increasingly observed to play a ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenfield, Graeme, McPherson, Suzanne, Smith, James, Mead, Adam, Harrison, Claire, Mills, Ken, McMullin, Mary Frances
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563593/
https://www.ncbi.nlm.nih.gov/pubmed/32962027
http://dx.doi.org/10.3390/cancers12092669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563593/
https://www.ncbi.nlm.nih.gov/pubmed/32962027
http://dx.doi.org/10.3390/cancers12092669

Ejemplares similares